Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | PLX-4720 | 19.9526 | uM | 3 | 625.00 | 556.96 | 1000.00 | 1048.75 | 0.9535 | 0.8984 |
| SK-BR-3 | NVP-TAE684 | 0.31623 | uM | 3 | 625.00 | 556.96 | 1262.00 | 1048.75 | 1.2033 | 1.4495 |
| SK-BR-3 | Nilotinib | 1 | uM | 3 | 625.00 | 556.96 | 1183.00 | 1048.75 | 1.1280 | 1.2821 |
| SK-BR-3 | PLX-4720 | 0.31623 | uM | 3 | 625.00 | 556.96 | 1218.00 | 1048.75 | 1.1614 | 1.3561 |
| SK-BR-3 | PLX-4720 | 0.01 | uM | 3 | 625.00 | 556.96 | 1025.00 | 1048.75 | 0.9774 | 0.9505 |
| SK-BR-3 | Etoposide | 0.031623 | uM | 3 | 625.00 | 556.96 | 1057.00 | 1048.75 | 1.0079 | 1.0172 |
| SK-BR-3 | Nilotinib | 3.1623 | uM | 3 | 625.00 | 556.96 | 1094.00 | 1048.75 | 1.0431 | 1.0947 |
| SK-BR-3 | 0 | uM | 3 | 625.00 | 556.96 | 1051.00 | 1048.75 | 1.0021 | 1.0047 | |
| SK-BR-3 | 0 | uM | 3 | 625.00 | 556.96 | 968.00 | 1048.75 | 0.9230 | 0.8320 | |
| SK-BR-3 | 0 | uM | 3 | 625.00 | 556.96 | 902.00 | 1048.75 | 0.8601 | 0.6956 | |
| SK-BR-3 | 0 | uM | 3 | 1250.00 | 1210.88 | 2222.00 | 2533.13 | 0.8772 | 0.7684 | |
| SK-BR-3 | 0 | uM | 3 | 1250.00 | 1210.88 | 2487.00 | 2533.13 | 0.9818 | 0.9658 | |
| SK-BR-3 | Etoposide | 10 | uM | 3 | 1250.00 | 1210.88 | 1080.00 | 2533.13 | 0.4264 | -0.1019 |
| SK-BR-3 | PLX-4720 | 0.031623 | uM | 3 | 1250.00 | 1210.88 | 2383.00 | 2533.13 | 0.9407 | 0.8885 |
| SK-BR-3 | NVP-TAE684 | 0.031623 | uM | 3 | 1250.00 | 1210.88 | 2581.00 | 2533.13 | 1.0189 | 1.0355 |
| SK-BR-3 | 0 | uM | 3 | 1250.00 | 1210.88 | 2551.00 | 2533.13 | 1.0071 | 1.0133 | |
| SK-BR-3 | Etoposide | 0.01 | uM | 3 | 1250.00 | 1210.88 | 2202.00 | 2533.13 | 0.8693 | 0.7535 |
| SK-BR-3 | NVP-TAE684 | 3.1623 | uM | 3 | 1250.00 | 1210.88 | 1181.00 | 2533.13 | 0.4662 | -0.0232 |
| SK-BR-3 | Etoposide | 0.31623 | uM | 3 | 1250.00 | 1210.88 | 1633.00 | 2533.13 | 0.6447 | 0.3243 |
| SK-BR-3 | PLX-4720 | 0.0033113 | uM | 3 | 1250.00 | 1210.88 | 2754.00 | 2533.13 | 1.0872 | 1.1633 |
| SK-BR-3 | NVP-TAE684 | 0.01 | uM | 3 | 1250.00 | 1210.88 | 2662.00 | 2533.13 | 1.0509 | 1.0954 |
| SK-BR-3 | Etoposide | 0.0033113 | uM | 3 | 1250.00 | 1210.88 | 2306.00 | 2533.13 | 0.9103 | 0.8311 |
| SK-BR-3 | PLX-4720 | 10 | uM | 3 | 1250.00 | 1210.88 | 2713.00 | 2533.13 | 1.0710 | 1.1331 |
| SK-BR-3 | Etoposide | 3.1623 | uM | 3 | 1250.00 | 1210.88 | 1476.00 | 2533.13 | 0.5827 | 0.2043 |
| SK-BR-3 | Nilotinib | 19.9526 | uM | 3 | 1250.00 | 1210.88 | 1048.00 | 2533.13 | 0.4137 | -0.1269 |